Granulomatous amoebic encephalitis laboratory tests

Granulomatous amoebic encephalitis Microchapters
Home
Patient Information
Overview
Pathophysiology
Causes
Differentiating Granulomatous amoebic encephalitis from other Diseases
Epidemiology and Demographics
Risk Factors
Natural history, Complications, and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
CT
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Primary Prevention
Case Studies
Case #1
Granulomatous amoebic encephalitis laboratory tests On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Granulomatous amoebic encephalitis laboratory tests All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Granulomatous amoebic encephalitis laboratory tests
CDC on Granulomatous amoebic encephalitis laboratory tests
Granulomatous amoebic encephalitis laboratory tests in the news
Blogs on Granulomatous amoebic encephalitis laboratory tests
Directions to Hospitals Treating Granulomatous amoebic encephalitis
Risk calculators and risk factors for Granulomatous amoebic encephalitis laboratory tests

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

The indirect immunofluorescence assay (IFA) is a test used to detect antibodies attached to Balamuthia amebas in body tissues. In contrast, immunohistochemistry (IHC) uses specific antibodies against Balamuthia to detect the amoebas. Finally, a polymerase chain reaction (PCR) molecular assay can detect Balamuthia DNA.

Laboratory Findings

Balamuthia Granulomatous Amebic Encephalitis (GAE) is a serious infection of the brain and spinal cord caused by Balamuthia. GAE is often diagnosed only after death. However, it can be diagnosed by examining blood, cerebrospinal fluid, and tissue samples from a living patient as well. Diagnosis of GAE in a living patient is less common because the amoebas are difficult to identify under the microscope, even with commonly used stains[5].

However, there are three types of tests that can help confirm the diagnosis of GAE. The indirect immunofluorescence assay (IFA) is a test used to detect antibodies attached to Balamuthia amebas in body tissues. In contrast, immunohistochemistry (IHC) uses specific antibodies against Balamuthia to detect the amoebas. Finally, a polymerase chain reaction (PCR) molecular assay can detect Balamuthia DNA.

The Centers for Disease Control and Prevention (CDC) offers diagnostic assistance for Balamuthia to physicians and scientists through DPDx.